Thromb Haemost 1970; 24(03/04): 487-494
DOI: 10.1055/s-0038-1654258
Originalarbeiten – Original Articles – Travaux Originaux
Schattauer GmbH

Immunological Identification of Three Urokinases

Eugene D. Day
1   Departments of Microbiology and Immunology and of Surgery, Duke University Medical Center Durham, N.C.27706 (USA)
,
Anne P. Ball
1   Departments of Microbiology and Immunology and of Surgery, Duke University Medical Center Durham, N.C.27706 (USA)
› Author Affiliations
Supported by Contract AT-(40-l)-3195 with the U.S. Atomic Energy Commission and by Grants HE-08929 and NB-06233 with the National Institutes of Health, USPHS.
Further Information

Publication History

Publication Date:
28 June 2018 (online)

Summary

A third urokinase has been detected by immunochemical tests in two clinical preparations of urokinase, one from Abbott and one from Sterling-Winthrop. It is component V in a series of components found in Sterling-Winthrop clinical urokinase. Components I and II are confined to Sterling-Winthrop urokinase whereas components III, IV, and V are present also in Abbott urokinase. Evidence suggests but does not prove that V is the SI component of Abbott; that IV is the S2 component of Abbott as well as the crystalline component of Sterling -Winthrop ; and that III is a higher molecular weight species of urokinase, unrelated to either IV or V, which may correspond to the 104,000 MW uroprotein of Doleschel and Auerswald. It is proposed that III be referred to as S3.

 
  • References

  • 1 Ball A. P, Day E. D. Immunological identification of two urokinases. Thrombos. Diathes. haemorrh. (Stuttg.) 24: 475 1970;
  • 2 Day E. D, Ball A. P, Jeffords D, Woodard Jr. W. T, Silver D. The immunoassay of human urokinase. Thrombos. Diathes. haemorrh. (Stuttg.) 21: 273 1969;
  • 3 White W. F, Barlow G. H, Mozen M. M. The isolation and characterization of plasminogen activators (urokinase) from human urine. Biochemistry 05: 2160 1966;
  • 4 LesuJc A, Terminiello L, Traver J. H. Crystalline human urokinase: Some properties. Science 147: 880 1965;
  • 5 Doleschel W, Auerswald W. Determination of molecular weight of uroprotein fractions with urokinase activity by means of molecular sieving. Med. Pharmacol. Exper 16: 225 1967;
  • 6 Hamberg U, Savolainen M-L. Studies on plasminogen activators II. A method for the separation of purified urokinase from small samples of urine. Acta chem. scand 20: 2551 1966;
  • 7 Ball A. P, Day E. D, Silver D. Binding studies of radioiodinated components of a fibrino- genolytic system as detected by density gradient ultracentrifugation. (In press.)
  • 8 Ball A. P. Ph. D. Dissertation. 1970